Blood test during heart surgery to predict heart failure in kids
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at a substance called sST2 in the blood of children having heart surgery. The goal is to see if sST2 levels can help doctors predict heart failure after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is having heart surgery that uses a heart-lung machine.
- You or your child can understand German well enough to agree to the study in German.
- Your child does not have a known genetic condition that limits life expectancy.
- Your child does not have a genetic syndrome that usually requires surgery on more than one organ.
- Your child weighs more than 5.5 pounds (2.5 kg) at the time of surgery.
- Your child is not already in another research study that tests a new medicine or treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children prepare for heart surgery or a heart catheterization. It will ask families to fill out questionnaires to help improve preoperative care.
This study looks at whether a simple blood test can predict a serious heart problem called low cardiac output syndrome after a child has heart surgery. Doctors hope this will help them spot and treat this issue earlier, which could lead to better recovery for your child.
This study looks at whether certain proteins in the blood (called Tau and GFAP) can predict brain injury after heart surgery in children. The goal is to find early warning signs to improve care and outcomes.
This study collects and analyzes small samples of heart tissue during specific heart operations in babies or children. The goal is to better understand how the heart develops after birth, which could improve future care.
This study looks at blood test results from people having heart surgery with a heart-lung machine. It will help doctors understand and improve the use of these tests.
This trial checks a blood test called NT-proBNP (a marker related to heart stress) to help predict outcomes after planned surgery. It may help doctors identify which patients are at higher risk so they can tailor monitoring and care.
Hear when a new Congenital Heart Disease in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.